Allergy Immunotherapy Market Segmentation:
Allergy Type Segment Analysis
Based on the allergy type, the allergic rhinitis segment is projected to account for a lucrative share of 71.9% in the allergy immunotherapy market during the forecast period. The dominance of the segment is attributable to the rising occurrence of allergic rhinitis across the world, which significantly contributes to the market expansion. The NLM report in July 2023 depicts that 30% of the general population are affected by allergic disease. Additionally, the push for advanced treatments such as subcutaneous immunotherapy, sublingual immunotherapy in rhinitis treatment is inspiring the global pharma leaders to invest in such therapeutic measures, driving the adoption of immunotherapy for rhinitis.
Treatment Type Segment Analysis
Based on treatment type, the subcutaneous immunotherapy segment is expected to garner the highest share by the end of 2035. The dominance of the segment is attributable to its capability to offer reliable solutions for severe allergies and develop resistance against allergens. According to the CDC report in January 2023, 1 in 5 children in the U.S. have seasonal allergy, and asthma. The subcutaneous immunotherapy demonstrated exceptional positive outcomes in treating conditions such as allergic rhinitis, asthma, and other allergic conditions. This is the evidence for a wider scope fueled by increasing healthcare access, well-established conventions, and proven efficacy of this element as a reliable solution.
Formulation Type Segment Analysis
Tablet dominates the form type segment used in sublingual immunotherapy and are preferred for patient compliance and convenience. CDC reports depicts increased home-administered treatment of allergic diseases owing to fewer clinic visit requirements over injections. Government-supported research underscores tablets’ safety and efficacy, which have enhanced patient acceptance and market expansion. FDA approvals of several SLIT tablet products for allergic rhinitis are a key factor driving growing adoption levels throughout the U.S. and North America healthcare systems.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Allergy Type |
|
|
Treatment Type |
|
|
Distribution Channel |
|
|
Formulation Type |
|
